Evaluation of the magnitude of the bronchodilator response in children and adolescents with asthma

Chest

Volumn 127, Issue 2, 2005, Pages 530-535

  Bussamra, Maria Helena ^a,b   Cukier, Alberto ^a   Stelmach, Rafael ^a   Rodrigues, Joaquim Carlos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Asthma; Bronchial obstruction; Bronchodilator response; Children

Indexed keywords

BRONCHODILATING AGENT; PLACEBO; SALBUTAMOL;

ADOLESCENT; AIRWAY CONDUCTANCE; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CHILD; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PARAMETER; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY;

EID: 13644251669     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.2.530     Document Type: Article

References (32)

1. Wanger J. Pulmonary function testing: a practical approach. 2nd ed. Philadelphia, PA; Williams & Wilkins, 1996; 1-76
2. National Heart, Lung, and Blood Institute/World Health Organization. Global strategy for asthma management and prevention: revised workshop report. Bethesda, MD: National Institutes of Health, 2000
3. Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests. Am J Respir Crit Care Med 1994; 149(Suppl):S9-S18
4. Gimeno F, Postma DS, Altena R. Plethysmographic parameters in the assessment of reversibility of airways obstruction in patients with emphysema. Chest 1993; 104:467-470
5. Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002; 121:1042-1050
6. Morice AH, Waterhouse JC, Peers EM, et al. Use of whole body plethysmography to compare bronchodilator inhaler efficacy. Respiration 1998; 65:120-124
7. Ruppel GL. Manual of pulmonary function testing. 7th ed. St. Louis, MO: Mosby, 1998; 27-68
8. Brand PLP, Quanjer PH, Postma DS, et al. Interpretation of bronchodilator response in patients with obstructive airways disease: The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax 1992; 47:429-436
9. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma: National Asthma Education and Prevention Program; highlights of the expert panel report II. Bethesda, MD: National Institutes of Health, 1997
10. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
11. American Association for Respiratory Care. AARC clinical practice guideline: body plethysmography. Respir Care 1994; 39:1184-1190
12. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. Philadelphia, PA: Saunders, 1971
13. Polgar G, Weng T. The functional development of the respiratory system from the period of gestation to adulthood. Am Rev Respir Dis 1979; 120:625-695
14. Rosner B. Fundamentals of biostatistics. 2nd ed. Boston, MA: PWS Publishers, 1986
15. Timm NH. Multivariate analysis with applications in education and psychology. Monterrey, CA: Brooks/Cole Publishing Company, 1975
16. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity: ATS Workshop on Lung Volume Measurements; Official Statement of the European Respiratory Society. Eur Respir J 1995; 8:492-506
17. Sourk RL, Nugent KM. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis 1983; 128:153-157
18. Jeffery PK. Comparison of the structural and inflammatory features of COPD and asthma. Chest 2000; 117(Suppl):251S-260S
19. Cassino C, Berger KI, Goldring RM, et al. Duration of asthma and physiologic outcomes in elderly nonsmokers. Am J Respir Crit Care Med 2000; 162:1423-1428
20. Martinez FD. Present and future treatment of asthma in infants and young children. J Allergy Clin Immunol 1999; 104:169-174
21. Harf A. How to express the reversibility of bronchial obstruction? Eur Respir J 1992; 5:919-920
22. Pereira CAC, Solé D. II. Consenso brasileiro no manejo da asma. J Pneumol 1998; 24:171-276
23. 1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax 1987; 42:487-490
24. Pereira CAC. I. Consenso brasileiro sobre espirometria. J Pneumol 1996; 22:105-164
25. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
26. Weir DC, Burge PS. Measures of reversibility in response to bronchodilators in chronic airflow obstruction: relation to airway caliber. Thorax 1991; 46:43-45
27. 1 on bronchodilator response in asthmatic patients. Respiration 2003; 70:54-59
28. 1. Eur Respir J 1992; 25:975-981
29. Kraemer R, Meister B, Schaad UB, et al. Reversibility of lung function abnormalities in children with perennial asthma. J Pediatr 1983; 102:347-350
30. Busse WW, Banks-Schlegel S, Wenzel S, et al. Pathophysiology of severe asthma. J Allergy Clin Immunol 2000; 106:1033-1042
31. Hellinckx J, De Boeck K, Bande-Knops J, et al. Bronchodilator response in 3-6.5 years old healthy and stable asthmatic children. Eur Respir J 1998; 12:438-443
32. Van Noord JA, Smeets J, Clément J, et al. Assessment of reversibility of airflow obstruction. Am J Respir Crit Care Med 1994; 150:551-554